Show simple item record

dc.contributor.authorJohannesson, Stephen
dc.date.accessioned2017-12-01T22:38:05Z
dc.date.available2017-12-01T22:38:05Z
dc.date.issued2016-07
dc.identifier.urihttp://jhir.library.jhu.edu/handle/1774.2/44588
dc.descriptionThe Studies in Applied Finance series is under the general direction of Prof. Steve H. Hanke, Co-Director of the Johns Hopkins Institute for Applied Economics, Global Health, and Study of Business Enterprise (hanke@jhu.edu) and Dr. Hesam Motlagh (hesamnmotlagh@gmail.com), a Fellow at the Johns Hopkins Institute for Applied Economics, Global Health, and Study of Business Enterprise. This working paper is one in a series on applied financial economics, which focuses on company valuations. The authors are mainly students at the Johns Hopkins University in Baltimore who have conducted their work at the Institute as undergraduate researchers.en_US
dc.description.abstractThis working paper is an in-depth analysis of Gilead Sciences, Inc. Our analysis examines the economic factors that impact Gilead’s underlying business and how the firm has adapted to these ever-changing factors. This economic analysis is then combined with our proprietary, Hanke-Guttridge Discounted Cash Flow (HG-DCF) model to determine Gilead’s financial position. The HG-DCF model will be presented along-side Monte-Carlo simulations to reveal the distribution of probable free cash flows, the likelihood of future earnings, and the degree to which the firm’s drug pipeline is being considered by the current market valuation. In addition to these quantitative factors, we also examine the compensation plans of Gilead’s executives to assess alignment with shareholders. At the conclusion of this analysis, it is our intention for readers to understand Gilead’s business plan and the company’s financial standing to arrive at a sound investment decision.en_US
dc.language.isoen_USen_US
dc.publisherInstitute for Applied Economics, Global Health, and the Study of Business Enterpriseen_US
dc.relation.ispartofseriesStudies in Applied Finance;9
dc.subjectfinanceen_US
dc.subjectinvestment thesisen_US
dc.subjectGilead Sciencesen_US
dc.subjectfinancial modelingen_US
dc.subjectdiscounted cash flowen_US
dc.subjectfree cash flowen_US
dc.subjectMonte-Carlo simulationen_US
dc.subjectmanagement compensationen_US
dc.titleInvestment Thesis for Gilead Sciences, Inc. (NYSE: GILD)en_US
dc.typeWorking Paperen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record